Breaking College Football Season Ushers In New Playoff Format, Rule Changes, and Commercialization Rory McIlroy Shares Lead at BMW Championship Amid Scottie Scheffler’s Struggles Hong Kong Court to Rule on National Security Charges for Tiananmen Commemoration Organizers Woman Arrested, Accused of Plotting ISIS-Inspired Attack on New York State Capitol Northwest Indiana Residents Endure Ninth Day Without Power After Deadly Storm; Central Ohio Faces Flash Flooding

Thursday August 20, 2026

Reporter

LEADS BIOLABS CO., LTD.

8Articles Published

5Communities Covered

Published Articles

Press Release

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

32 minutes ago

Press Release

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

2 hours ago

Press Release

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

10 hours ago

Press Release

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

10 hours ago

Press Release

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Hepatocellular Carcinoma Following Positive Efficacy Signals

Aug 5

Press Release

Leads Biolabs Announces Partner Oblenio Bio Doses First Patients in Phase 1a Trial of LBL‑051 for Refractory Autoimmune Diseases

Aug 4

Press Release

Leads Biolabs’ PD-L1/4-1BB Bispecific Antibody IND Application for Combination Therapy in Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise

Aug 2

Press Release

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Completes Patient Enrollment in Phase II Study for Biliary Tract Cancer, Further Demonstrating Breakthrough Potential in Immune-Cold Tumors

Jul 30